We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks dip on surging virus cases, stimulus doubts

Mon, 26th Oct 2020 13:22

* Unease over record virus cases in Europe, U.S.

* German DAX hits three-month low as SAP slumps

* Investors seek dollar safety

* Italy bond yields slide after S&P move

* Eyes this week on central bank meetings, U.S. GDP data

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Tom Arnold and Wayne Cole

LONDON/SYDNEY, Oct 26 (Reuters) - Global shares fell on
Monday as surging coronavirus cases in Europe and the United
States clouded the global economic outlook, while China's
leaders meet to plan the country's economic future.

The United States has seen its highest-ever number of new
COVID-19 cases in the past two days. France also set case
records and Spain announced a state of emergency.

The coronavirus resurgence, along with no clear progress on
a U.S. stimulus package and caution before the Nov. 3 U.S.
election, dragged the MSCI world equity index
down 0.3%. In Europe, the Euro STOXX 600 shed 1%. S&P
500 futures fell 1%.

"The decreasing likelihood of U.S. fiscal stimulus
pre-election, possibly even pre-year-end, as well as worsening
virus numbers and increasing lockdown measures, all seem to be
taking the shine off what was a rather complacent market view of
the outlook," said James Athey, investment director at Aberdeen
Standard Investments.

Europe became the second region after Latin America to
surpass 250,000 deaths on Saturday, according to a Reuters
tally, as many European countries reported their highest number
of COVID-19 cases in a single day.

Milan's blue-chip index sank 1% as new curbs on
public venues overshadowed Friday's news that ratings agency S&P
Global had upgraded the nation's sovereign outlook to stable
from negative.

The German DAX slumped 2.7% to a three-month low
after software company SAP abandoned medium-term
profitability targets and warned its business would take longer
than expected to recover from the pandemic.

Sentiment was also hit by a survey showing German business
morale fell for the first time in six months in October.

Reports of progress in a COVID-19 vaccine being developed by
the University of Oxford and manufactured by drug maker
AstraZeneca Plc helped limit some of the market
sell-off, analysts said.

MSCI's broadest index of Asia-Pacific shares outside Japan
shed 0.2%. Japan's Nikkei finished 1%
lower, and South Korea's main index lost 0.7%.

Chinese blue chips shed 0.6% as the country's
leaders met to chart the nation's economic course for 2021-2025,
balancing growth with reforms amid an uncertain global outlook
and worsening relations with the United States.

In a packed week for monetary policy decisions, Canada's and
Japan's central banks are expected to hold fire for now. Markets
assume the European Central Bank will sound cautious on
inflation and growth even if it skips a further easing.

Data due out Thursday is forecast to show a consumer-led
31.9% rebound in U.S. economic output in the third quarter,
after the second quarter's historic collapse.

Analysts at Westpac noted such a bounce would still leave
2020 GDP around 4% below last year's, with business investment
still lagging badly.

As markets increasingly price in the likelihood of a
Democratic president and Congress and resulting rise in
government spending and borrowing, U.S. 10-year Treasury yields
hit their highest since early June last week at 0.8720%
. They were trading at 0.81% on Monday.

"We have raised the probability of a Democratic sweep,
already our base case, from 40% to just over 50% and have
increased our expectation of Biden to win from 65% to 75%,"
NatWest Markets analysts said. "We see steeper U.S. yield curves
and a weaker USD as likely to prevail in our base case."

Italian government bond yields slid across the curve, with
short-dated yields falling to a one-year low, after S&P Global's
unexpected outlook upgrade.

The benchmark 10-year yield dropped 6 basis points to 0.70%
. Short-dated two-year Italian yields hit
their lowest level in a year at -0.382%.

Surging coronavirus cases sent investors to the safety of
the dollar after it fell broadly last week.

An index tracking its value against a basket of currencies
firmed 0.1% to 92.92, while euro/dollar - the most traded
currency pair and part of the index - fell 0.3% to 1.1826
.

In commodity markets, gold was 0.1% higher at
$1,902.06 per ounce.

Oil prices extended last week's losses as the prospect of
increased supply and resurgent coronavirus infections worried
investors.

Brent crude was down 1.9% at $40.97 a barrel. U.S.
West Texas Intermediate (WTI) dropped 2.1% to $39.03.

(Reporting by Tom Arnold in London and Wayne Cole in Sydney;
editing by Shri Navaratnam, Tomasz Janowski, Larry King)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.